ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Probiotic Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-32L16974
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Probiotic Infant Formula Market Research Report 2024
BUY CHAPTERS

Global Probiotic Infant Formula Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32L16974
Report
November 2025
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Enfamil
envivo
Nestlé Health Science
Bellamy’s Organic
HiPP
Custom Probiotics, Inc.
Similac
New Beginnings Nutritionals
SFl Health
Nutricia Neocate

Probiotic Infant Formula Market

The global Probiotic Infant Formula market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Probiotic infant formula is a type of baby formula that contains live beneficial bacteria, such as Bifidobacterium infantis or Lactobacillus rhamnosus. These probiotics are believed to promote a healthy balance of gut bacteria in infants, which may help support digestion, boost the immune system, and prevent certain health issues like colic or eczema.
From a downstream perspective, Supermarket accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Probiotic Infant Formula leading manufacturers including Enfamil, Envivo, Nestlé Health Science, New Beginnings Nutritionals, Bellamy's Organic, HiPP, Custom Probiotics Inc., SFl Health, Similac, Nutricia Neocate, etc., dominate supply; the top five capture approximately % of global revenue, with Enfamil leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Probiotic Infant Formula market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Probiotic Infant Formula Market Report

Report Metric Details
Report Name Probiotic Infant Formula Market
Segment by Type
  • Premature
  • Infant
  • Toddler
Segment by Application
  • Supermarket
  • Specialty Store
  • Online Sales
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Enfamil, Envivo, Nestlé Health Science, New Beginnings Nutritionals, Bellamy's Organic, HiPP, Custom Probiotics Inc., SFl Health, Similac, Nutricia Neocate
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Probiotic Infant Formula study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Probiotic Infant Formula Market report?

Ans: The main players in the Probiotic Infant Formula Market are Enfamil, Envivo, Nestlé Health Science, New Beginnings Nutritionals, Bellamy's Organic, HiPP, Custom Probiotics Inc., SFl Health, Similac, Nutricia Neocate

What are the Application segmentation covered in the Probiotic Infant Formula Market report?

Ans: The Applications covered in the Probiotic Infant Formula Market report are Supermarket, Specialty Store, Online Sales, Other

What are the Type segmentation covered in the Probiotic Infant Formula Market report?

Ans: The Types covered in the Probiotic Infant Formula Market report are Premature, Infant, Toddler

1 Study Coverage
1.1 Introduction to Probiotic Infant Formula: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Probiotic Infant Formula Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Premature
1.2.3 Infant
1.2.4 Toddler
1.3 Market Segmentation by Application
1.3.1 Global Probiotic Infant Formula Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Supermarket
1.3.3 Specialty Store
1.3.4 Online Sales
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Probiotic Infant Formula Revenue Estimates and Forecasts 2020-2031
2.2 Global Probiotic Infant Formula Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Probiotic Infant Formula Sales Estimates and Forecasts 2020-2031
2.4 Global Probiotic Infant Formula Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Probiotic Infant Formula Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Probiotic Infant Formula Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Premature Market Size by Manufacturers
3.5.2 Infant Market Size by Manufacturers
3.5.3 Toddler Market Size by Manufacturers
3.6 Global Probiotic Infant Formula Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Probiotic Infant Formula Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Probiotic Infant Formula Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Probiotic Infant Formula Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Probiotic Infant Formula Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Probiotic Infant Formula Sales and Revenue by Type (2020-2031)
6.4 North America Probiotic Infant Formula Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Probiotic Infant Formula Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Probiotic Infant Formula Sales and Revenue by Type (2020-2031)
7.4 Europe Probiotic Infant Formula Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Probiotic Infant Formula Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Probiotic Infant Formula Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Probiotic Infant Formula Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Probiotic Infant Formula Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Probiotic Infant Formula Sales and Revenue by Type (2020-2031)
9.4 Central and South America Probiotic Infant Formula Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Probiotic Infant Formula Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Probiotic Infant Formula Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Probiotic Infant Formula Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Probiotic Infant Formula Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Enfamil
11.1.1 Enfamil Corporation Information
11.1.2 Enfamil Business Overview
11.1.3 Enfamil Probiotic Infant Formula Product Models, Descriptions and Specifications
11.1.4 Enfamil Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Enfamil Probiotic Infant Formula Sales by Product in 2024
11.1.6 Enfamil Probiotic Infant Formula Sales by Application in 2024
11.1.7 Enfamil Probiotic Infant Formula Sales by Geographic Area in 2024
11.1.8 Enfamil Probiotic Infant Formula SWOT Analysis
11.1.9 Enfamil Recent Developments
11.2 Envivo
11.2.1 Envivo Corporation Information
11.2.2 Envivo Business Overview
11.2.3 Envivo Probiotic Infant Formula Product Models, Descriptions and Specifications
11.2.4 Envivo Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Envivo Probiotic Infant Formula Sales by Product in 2024
11.2.6 Envivo Probiotic Infant Formula Sales by Application in 2024
11.2.7 Envivo Probiotic Infant Formula Sales by Geographic Area in 2024
11.2.8 Envivo Probiotic Infant Formula SWOT Analysis
11.2.9 Envivo Recent Developments
11.3 Nestlé Health Science
11.3.1 Nestlé Health Science Corporation Information
11.3.2 Nestlé Health Science Business Overview
11.3.3 Nestlé Health Science Probiotic Infant Formula Product Models, Descriptions and Specifications
11.3.4 Nestlé Health Science Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Nestlé Health Science Probiotic Infant Formula Sales by Product in 2024
11.3.6 Nestlé Health Science Probiotic Infant Formula Sales by Application in 2024
11.3.7 Nestlé Health Science Probiotic Infant Formula Sales by Geographic Area in 2024
11.3.8 Nestlé Health Science Probiotic Infant Formula SWOT Analysis
11.3.9 Nestlé Health Science Recent Developments
11.4 New Beginnings Nutritionals
11.4.1 New Beginnings Nutritionals Corporation Information
11.4.2 New Beginnings Nutritionals Business Overview
11.4.3 New Beginnings Nutritionals Probiotic Infant Formula Product Models, Descriptions and Specifications
11.4.4 New Beginnings Nutritionals Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 New Beginnings Nutritionals Probiotic Infant Formula Sales by Product in 2024
11.4.6 New Beginnings Nutritionals Probiotic Infant Formula Sales by Application in 2024
11.4.7 New Beginnings Nutritionals Probiotic Infant Formula Sales by Geographic Area in 2024
11.4.8 New Beginnings Nutritionals Probiotic Infant Formula SWOT Analysis
11.4.9 New Beginnings Nutritionals Recent Developments
11.5 Bellamy's Organic
11.5.1 Bellamy's Organic Corporation Information
11.5.2 Bellamy's Organic Business Overview
11.5.3 Bellamy's Organic Probiotic Infant Formula Product Models, Descriptions and Specifications
11.5.4 Bellamy's Organic Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Bellamy's Organic Probiotic Infant Formula Sales by Product in 2024
11.5.6 Bellamy's Organic Probiotic Infant Formula Sales by Application in 2024
11.5.7 Bellamy's Organic Probiotic Infant Formula Sales by Geographic Area in 2024
11.5.8 Bellamy's Organic Probiotic Infant Formula SWOT Analysis
11.5.9 Bellamy's Organic Recent Developments
11.6 HiPP
11.6.1 HiPP Corporation Information
11.6.2 HiPP Business Overview
11.6.3 HiPP Probiotic Infant Formula Product Models, Descriptions and Specifications
11.6.4 HiPP Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 HiPP Recent Developments
11.7 Custom Probiotics Inc.
11.7.1 Custom Probiotics Inc. Corporation Information
11.7.2 Custom Probiotics Inc. Business Overview
11.7.3 Custom Probiotics Inc. Probiotic Infant Formula Product Models, Descriptions and Specifications
11.7.4 Custom Probiotics Inc. Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Custom Probiotics Inc. Recent Developments
11.8 SFl Health
11.8.1 SFl Health Corporation Information
11.8.2 SFl Health Business Overview
11.8.3 SFl Health Probiotic Infant Formula Product Models, Descriptions and Specifications
11.8.4 SFl Health Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 SFl Health Recent Developments
11.9 Similac
11.9.1 Similac Corporation Information
11.9.2 Similac Business Overview
11.9.3 Similac Probiotic Infant Formula Product Models, Descriptions and Specifications
11.9.4 Similac Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Similac Recent Developments
11.10 Nutricia Neocate
11.10.1 Nutricia Neocate Corporation Information
11.10.2 Nutricia Neocate Business Overview
11.10.3 Nutricia Neocate Probiotic Infant Formula Product Models, Descriptions and Specifications
11.10.4 Nutricia Neocate Probiotic Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Nutricia Neocate Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Probiotic Infant Formula Industry Chain
12.2 Probiotic Infant Formula Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Probiotic Infant Formula Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Probiotic Infant Formula Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Probiotic Infant Formula Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Probiotic Infant Formula Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Enfamil
envivo
Nestlé Health Science
Bellamy’s Organic
HiPP
Custom Probiotics, Inc.
Similac
New Beginnings Nutritionals
SFl Health
Nutricia Neocate
List of Tables
 Table 1. Global Probiotic Infant Formula Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Probiotic Infant Formula Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Probiotic Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Probiotic Infant Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Probiotic Infant Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Probiotic Infant Formula Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Probiotic Infant Formula Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Probiotic Infant Formula Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Probiotic Infant Formula Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 11. Global Probiotic Infant Formula Sales Share by Manufacturers (2020-2025)
 Table 12. Global Probiotic Infant Formula Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Probiotic Infant Formula Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Probiotic Infant Formula by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Probiotic Infant Formula as of 2024)
 Table 16. Global Probiotic Infant Formula Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Probiotic Infant Formula Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Probiotic Infant Formula Manufacturing Base and Headquarters
 Table 19. Global Probiotic Infant Formula Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Probiotic Infant Formula Sales by Type (2020-2025) & (Kilotons)
 Table 23. Global Probiotic Infant Formula Sales by Type (2026-2031) & (Kilotons)
 Table 24. Global Probiotic Infant Formula Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Probiotic Infant Formula Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Probiotic Infant Formula ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Probiotic Infant Formula Sales by Application (2020-2025) & (Kilotons)
 Table 29. Global Probiotic Infant Formula Sales by Application (2026-2031) & (Kilotons)
 Table 30. Probiotic Infant Formula High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Probiotic Infant Formula Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Probiotic Infant Formula Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Probiotic Infant Formula ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Probiotic Infant Formula Growth Accelerators and Market Barriers
 Table 37. North America Probiotic Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Probiotic Infant Formula Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Probiotic Infant Formula Growth Accelerators and Market Barriers
 Table 40. Europe Probiotic Infant Formula Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Probiotic Infant Formula Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Probiotic Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Probiotic Infant Formula Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Probiotic Infant Formula Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Probiotic Infant Formula Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Probiotic Infant Formula Investment Opportunities and Key Challenges
 Table 47. Central and South America Probiotic Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Probiotic Infant Formula Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Probiotic Infant Formula Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Enfamil Corporation Information
 Table 51. Enfamil Description and Major Businesses
 Table 52. Enfamil Product Models, Descriptions and Specifications
 Table 53. Enfamil Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. Enfamil Sales Value Proportion by Product in 2024
 Table 55. Enfamil Sales Value Proportion by Application in 2024
 Table 56. Enfamil Sales Value Proportion by Geographic Area in 2024
 Table 57. Enfamil Probiotic Infant Formula SWOT Analysis
 Table 58. Enfamil Recent Developments
 Table 59. Envivo Corporation Information
 Table 60. Envivo Description and Major Businesses
 Table 61. Envivo Product Models, Descriptions and Specifications
 Table 62. Envivo Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Envivo Sales Value Proportion by Product in 2024
 Table 64. Envivo Sales Value Proportion by Application in 2024
 Table 65. Envivo Sales Value Proportion by Geographic Area in 2024
 Table 66. Envivo Probiotic Infant Formula SWOT Analysis
 Table 67. Envivo Recent Developments
 Table 68. Nestlé Health Science Corporation Information
 Table 69. Nestlé Health Science Description and Major Businesses
 Table 70. Nestlé Health Science Product Models, Descriptions and Specifications
 Table 71. Nestlé Health Science Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. Nestlé Health Science Sales Value Proportion by Product in 2024
 Table 73. Nestlé Health Science Sales Value Proportion by Application in 2024
 Table 74. Nestlé Health Science Sales Value Proportion by Geographic Area in 2024
 Table 75. Nestlé Health Science Probiotic Infant Formula SWOT Analysis
 Table 76. Nestlé Health Science Recent Developments
 Table 77. New Beginnings Nutritionals Corporation Information
 Table 78. New Beginnings Nutritionals Description and Major Businesses
 Table 79. New Beginnings Nutritionals Product Models, Descriptions and Specifications
 Table 80. New Beginnings Nutritionals Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. New Beginnings Nutritionals Sales Value Proportion by Product in 2024
 Table 82. New Beginnings Nutritionals Sales Value Proportion by Application in 2024
 Table 83. New Beginnings Nutritionals Sales Value Proportion by Geographic Area in 2024
 Table 84. New Beginnings Nutritionals Probiotic Infant Formula SWOT Analysis
 Table 85. New Beginnings Nutritionals Recent Developments
 Table 86. Bellamy's Organic Corporation Information
 Table 87. Bellamy's Organic Description and Major Businesses
 Table 88. Bellamy's Organic Product Models, Descriptions and Specifications
 Table 89. Bellamy's Organic Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Bellamy's Organic Sales Value Proportion by Product in 2024
 Table 91. Bellamy's Organic Sales Value Proportion by Application in 2024
 Table 92. Bellamy's Organic Sales Value Proportion by Geographic Area in 2024
 Table 93. Bellamy's Organic Probiotic Infant Formula SWOT Analysis
 Table 94. Bellamy's Organic Recent Developments
 Table 95. HiPP Corporation Information
 Table 96. HiPP Description and Major Businesses
 Table 97. HiPP Product Models, Descriptions and Specifications
 Table 98. HiPP Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. HiPP Recent Developments
 Table 100. Custom Probiotics Inc. Corporation Information
 Table 101. Custom Probiotics Inc. Description and Major Businesses
 Table 102. Custom Probiotics Inc. Product Models, Descriptions and Specifications
 Table 103. Custom Probiotics Inc. Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 104. Custom Probiotics Inc. Recent Developments
 Table 105. SFl Health Corporation Information
 Table 106. SFl Health Description and Major Businesses
 Table 107. SFl Health Product Models, Descriptions and Specifications
 Table 108. SFl Health Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 109. SFl Health Recent Developments
 Table 110. Similac Corporation Information
 Table 111. Similac Description and Major Businesses
 Table 112. Similac Product Models, Descriptions and Specifications
 Table 113. Similac Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 114. Similac Recent Developments
 Table 115. Nutricia Neocate Corporation Information
 Table 116. Nutricia Neocate Description and Major Businesses
 Table 117. Nutricia Neocate Product Models, Descriptions and Specifications
 Table 118. Nutricia Neocate Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 119. Nutricia Neocate Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Probiotic Infant Formula Product Picture
 Figure 2. Global Probiotic Infant Formula Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Premature Product Picture
 Figure 4. Infant Product Picture
 Figure 5. Toddler Product Picture
 Figure 6. Global Probiotic Infant Formula Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Supermarket
 Figure 8. Specialty Store
 Figure 9. Online Sales
 Figure 10. Other
 Figure 11. Probiotic Infant Formula Report Years Considered
 Figure 12. Global Probiotic Infant Formula Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Probiotic Infant Formula Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Probiotic Infant Formula Revenue Market Share by Region (2020-2031)
 Figure 16. Global Probiotic Infant Formula Sales (2020-2031) & (Kilotons)
 Figure 17. Global Probiotic Infant Formula Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 18. Global Probiotic Infant Formula Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Probiotic Infant Formula Sales Volume Market Share in 2024
 Figure 20. Global Probiotic Infant Formula Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Premature Revenue Market Share by Manufacturer in 2024
 Figure 23. Infant Revenue Market Share by Manufacturer in 2024
 Figure 24. Toddler Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Probiotic Infant Formula Sales Market Share by Type (2020-2031)
 Figure 26. Global Probiotic Infant Formula Revenue Market Share by Type (2020-2031)
 Figure 27. Global Probiotic Infant Formula Sales Market Share by Application (2020-2031)
 Figure 28. Global Probiotic Infant Formula Revenue Market Share by Application (2020-2031)
 Figure 29. North America Probiotic Infant Formula Sales YoY (2020-2031) & (Kilotons)
 Figure 30. North America Probiotic Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Probiotic Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 32. North America Probiotic Infant Formula Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 33. North America Probiotic Infant Formula Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Probiotic Infant Formula Sales Volume (Kilotons) by Application (2020-2031)
 Figure 35. North America Probiotic Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Probiotic Infant Formula Sales YoY (2020-2031) & (Kilotons)
 Figure 40. Europe Probiotic Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Probiotic Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Probiotic Infant Formula Sales Volume (Kilotons) by Type (2020-2031)
 Figure 43. Europe Probiotic Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Probiotic Infant Formula Sales Volume (Kilotons) by Application (2020-2031)
 Figure 45. Europe Probiotic Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 47. France Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Probiotic Infant Formula Sales YoY (2020-2031) & (Kilotons)
 Figure 52. Asia-Pacific Probiotic Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Probiotic Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Probiotic Infant Formula Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 55. Asia-Pacific Probiotic Infant Formula Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Probiotic Infant Formula Sales Volume (Kilotons) by Application (2020-2031)
 Figure 57. Asia-Pacific Probiotic Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 62. India Probiotic Infant Formula Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Probiotic Infant Formula Sales YoY (2020-2031) & (Kilotons)
 Figure 64. Central and South America Probiotic Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Probiotic Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Probiotic Infant Formula Sales Volume (Kilotons) by Type (2021-2031)
 Figure 67. Central and South America Probiotic Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Probiotic Infant Formula Sales Volume (Kilotons) by Application (2020-2031)
 Figure 69. Central and South America Probiotic Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Probiotic Infant Formula Sales YoY (2020-2031) & (Kilotons)
 Figure 73. Middle East and Africa Probiotic Infant Formula Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Probiotic Infant Formula Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Probiotic Infant Formula Sales Volume (Kilotons) by Type (2021-2031)
 Figure 76. South America Probiotic Infant Formula Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Probiotic Infant Formula Sales Volume (Kilotons) by Application (2020-2031)
 Figure 78. Middle East and Africa Probiotic Infant Formula Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Probiotic Infant Formula Revenue (2020-2025) & (US$ Million)
 Figure 83. Probiotic Infant Formula Industry Chain Mapping
 Figure 84. Regional Probiotic Infant Formula Manufacturing Base Distribution (%)
 Figure 85. Global Probiotic Infant Formula Production Market Share by Region (2020-2031)
 Figure 86. Probiotic Infant Formula Production Process
 Figure 87. Regional Probiotic Infant Formula Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Infant Lactobacillus Powder Market Research Report 2024
Prebiotics for Infant Formula Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infant and Kids Probiotics Market Research Report 2024
Global Baby Probiotics Market Research Report 2024
Global Infant Bifidobacterium Powder Market Research Report 2024
Global Infant Probiotics Raw Material Powder Market Research Report 2025
Global Gentle Organic Infant Formula Market Research Report 2025
Global Infant and Young Children Formula Food Market Research Report 2025
Global Probiotic for Kids Market Research Report 2024
Global Bifidobacterium Infantis Market Research Report 2024
Global Maternal and Infant Probiotics Market Research Report 2025
Organic Infant Formula Milk Powder Market
Global Lactose Free Infant Formula Market Research Report 2024
Global Probiotics Dietary Supplements Market Research Report 2024
Global Probiotics Based Dietary Supplement Market Research Report 2025
Global Bifidobacteria Probiotic Market Research Report 2025
Global Baby Foods and Infant Formula Market Research Report 2024
Global Stage 3 Infant Formula Market Research Report 2024
Global Probiotic Powder Market Research Report 2025
Global Probiotic Dietary Supplement Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions